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At the time of this analysis 17 pts (38%) are alive without evidence of 
disease. Updated and mature disease-free and overall survival results 
will be available by the time of the meeting. 
Conclusions: This combined multimodality treatment strategy includ-
ing a third generation chemotherapy regimen and accelerated RT is 
feasible. Toxicity is considerable but manageable. A clinical response 
was observed in two thirds of patients allowing to proceed with surgery 
for initially unresectable tumors. 
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Background: Previous reports describe the separation of reactive 
mesothelial proliferations from malignant mesothelioma on small 
biopsy can be quite difﬁcult. Medical thoracoscopy using a semiﬂex-
ible thoracoscope has been performed for unexplained pleural effusion 
but because of small biopsies, occasionally fails to make a diagnosis. 
In 1996, some Japanese gastrointestinal endoscopists developed a 
special endoscope knife, called the insulation-tipped diathermic knife 
(IT knife, Olympus). This knife can incise gastric mucosa safely and 
remove a lesion completely. We deviced a novel thoracoscopic pleural 
biopsy technique using IT knife for the diagnosis of unexplained pleu-
ral effusion, and assessed the feasibility.
Patients and Methods: From January 2006 to January 2007, twenty 
patients with unexplained pleural effusion underwent diagnostic medical 
thoracoscopy. Nine of 20 patients that were difﬁcult to grasp by using 
ﬂexible forceps because of extensive reactive proliferation of the pleura 
were investigated. The patient was placed in the lateral decubitus posi-
tion, and an 8-mm ﬂexible trocar was inserted with the single puncture 
technique. Semiﬂexible thoracoscope (LTF-240, Olympus) was inserted 
through a ﬂexible trocar, and the whole chest cavity was observed. After 
conﬁrming the area of pleural lesion, a subpleural injection of saline 
containing lidokine and epinephrine was performed until the pleura were 
raised. After a pin hole was made, the tip of the IT knife was inserted 
into the hole. The pleura around the lesion were incised in a circle by 
manipulating the IT knife with the 40W ENDO-CUT.
Results: A deﬁnitive diagnosis was established in all patients. The 
mean time taken for the procedure and longest diameter of the speci-
men were 22.4±10.7 minutes and 15.3±10.8 mm, respectively. The 
following diseases were diagnosed: mesothelioma in three patients, 
malignant lymphoma in one, metastasis of breast cancer in one, lung 
adenocarcinoma in one, tuberculosis in one, and nonspeciﬁc inﬂam-
mation in two. Three of the nine patients (desmoplastic mesothelioma, 
metastasis of breast cancer, nonspeciﬁc inﬂammation) were only 
diagnosed using this technique, and not by using ﬂexible forceps. There 
were no severe complications during the procedure.
Conclusions: Thoracoscopic en-bloc pleural biopsy using the IT knife 
could be performed safely and adequately. This procedure may become 
an additional diagnostic modality for pleural effusion.
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Background: There has been no in-depth report on the beneﬁts of 
airway stenting focusing speciﬁcally on patients with inoperable ad-
vanced lung cancer with severe central airway obstruction. To address 
the beneﬁt of airway stenting, we evaluated the role of stent placement 
as one aspect of the multidisciplinary approach to the management of 
advanced lung cancer. 
Patients and Methods: Airway stenting was performed in 40 lung can-
cer patients, employing 58 stents. Adjuvant therapy (chemotherapy and/
or radiotherapy) was not performed in 22 patients after stenting (group 
A), while the other 18 patients did receive adjuvant therapy (group B).
Results: Scores of performance status and Hugh-Jones classiﬁcation 
improved in both groups after stenting: 3.56 to 2.48 (p=0.001) and 
4.29 to 3.20 (p=0.004) in group A, 3.15 to 1.25 (p=<0.001) and 4.10 
to 2.10 (p=<0.001) in group B. Improvement was dramatic in group B. 
Eight patients had hemoptysis after stenting, 7 in group A (31.8%) and 
1 in group B (5.6%). Six of 8 patients (75.0%) received placement of 
multiple stents. Overall survival curves by Kaplan-Meier estimate after 
airway stenting for inoperable NSCLC are shown in Figure 1. Group 
A had a clearly poor outcome (median survival time: 1.6 months, 1-
year survival: 5.1%) after stenting. Meanwhile, group B showed more 
encouraging results (MST: 5.6 months, 1-year survival: 25.0%). There 
was a signiﬁcant difference in survival between the 2 groups (p=0.002).
Conclusions: Signiﬁcant improvement of QOL and survival beneﬁt by 
stent placement was particularly seen in treatment-naïve patients who 
could receive post-stenting adjuvant therapy. Patients not responding 
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to previous treatment may not reap the beneﬁt of survival improve-
ment because they were already in a terminal stage at the time of stent 
placement. Interventional pulmonologists should be aware of the dis-
couraging prognosis and the risk of impediments for terminal patients, 
especially in cases of multiple stent placements. 
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Background: Lung cancer accounts for more deaths than breast, pros-
tate and colon cancers combined. Prognosis and survival depend on the 
stage of disease, and since more than two thirds of patients with lung 
cancer have mediastinal lymph node or distant metastases at presenta-
tion, it is not surprising that cure rate remains dismal at 15%.
Aim: To determine if early detection and intervention for central air-
way lung cancer could impact outcome of patients at risk.
Methods: All current or former smokers with ≥1 aerodigestive cancers 
were recruited for the program beginning January 1996 to December 
2005 and prospectively followed till December 2006. Autoﬂuores-
cence bronchoscopy was performed with LIFE® (Xilix, BC, Richmond 
Canada) every 3-6 months, and where indicated, bronchoscopic treat-
ment was applied as an alternative to surgery or to enable less exten-
sive resection whenever feasible. Values are presented as median and 
range, and lung cancer related mortality is calculated by Kaplan Meier 
method.
Results: There were 228 individuals, 190 males with median age 69 
years (range, 62-75). They smoked 40 median pack years (range, 34-
50), and 70% had COPD with median FEV1 % predicted 53% (range, 
39-70). Follow-up was 40 months (range, 22-79), and the indications 
were: surveillance after lung cancer surgery in 94 patients (41%); 
previous ENT cancer in 32 (14%); suspected occult lung cancer in 92 
(41%); and known lung cancer in 10 (4%). There were 111 patients 
with one lung cancer, and 99 with 2 or more lung cancers. A total of 
217 new lung cancers were diagnosed: AF detected 181 and 36 by CT. 
Of the 92 patients with intraluminal squamous cell cancers (ISCC), 12 
(13%) underwent surgery with one requiring post-operative radio-
therapy (RT), 10 (11%) had RT alone and one (1%) received concurrent 
chemoradiotherapy. The remaining 69 patients (75%) had their multiple 
ISCC treated with endobronchial electrosurgery or cryotherapy. At the 
end of our study period, 123 individuals (54%) were alive, and 105 
(46%) deceased. Lung cancer-related mortality (Fig 1) was 21% (6.3%/ 
year) and the all cause mortality was 46%. 
Conclusions: Our results validate efforts towards early detection and 
intervention for this high risk group with ≥ 1 cancers. Bronchoscopic 
treatment could emerge as an effective alternative to surgery for early 
detected ISCC. 
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Background: The bronchial mucosa is the tissue ﬁrst exposed to dif-
ferent cancerogenes including tobacco smoke. Pathologic changes in 
the mucosa evolve from basal cell hyperplasia to epithelial dysplasia 
and cancer in situ. This process causes subtle changes in chemical 
composition and blood supply of mucosa and thickness of the basal 
membrane. This is why the processing of autoﬂuorescent signal from 
the bronchial mucosal surface is gaining increasing interest recently. 
Signiﬁcant weakness of commercial autoﬂuorescence systems is low 
speciﬁcity caused by decreased ﬂuorescence of the mucosa changed by 
chronic inﬂammation or other non-malignant endobronchial conditions. 
Methods: In order to increase speciﬁcity of the auto ﬂuorescent device 
we have tested system utilizing spectroscopic point monitoring of sus-
picious endobronchial locations. Every AFB positive location has been 
measured by this system and than visualized by NBI system. Evaluated 
group consisted of 30 patients with autoﬂuorescence positive endobron-
chial locations. 
Results and Conclusion: We have picked up some typical differences 
in autoﬂuorescence spectra’s between malignant and non-malignant 
tissues which are shown in graphs. We have also found that NBI tissue 
characteristics are very useful in discriminating between endobronchial 
